Keywords
Dear Editor,
Dahl et al., 2022
recently warned in this journal that armed conflict and human displacement by the Russia-Ukraine conflict may increase the burden of tuberculosis in Europe, but there could be more public health problems ahead. Since last 2 years, the COVID-19 pandemic has been an important catalyst for international collaboration on public health (Jit et al., 2021
). This collaboration has not been error-free, especially in relation to an equitable distribution of diagnostic tests, treatments, and vaccines between high-income and low-middle-income countries (- Jit M
- Ananthakrishnan A
- McKee M
- Wouters OJ
- Beutels P
- Teerawattananon Y.
Multi-country collaboration in responding to global infectious disease threats: lessons for Europe from the COVID-19 pandemic.
Lancet Reg Health Eur. 2021; 9100221https://doi.org/10.1016/j.lanepe.2021.100221
Javed and Chattu, 2020
).The pandemic has been, at least temporarily, a kind of freezer of major war conflicts worldwide owing to the joint efforts to mitigate its impact. A better understanding of the virus, growing herd immunity produced by COVID-19 vaccines and/or previous infection (
Randolph and Barreiro, 2020
; Radbruch and Chang, 2021
), and the transition to less lethal variants (Petersen et al., 2022
) have coincided with the beginning of a warfare in East Europe. The immediate consequences for Ukraine and surrounding regions are COVID-19 surges, unattended chronic diseases, emerging infections and lower vaccination rates, including anti-COVID-19 vaccination.The risk of an escalation is latent and consequences are unimaginable if nuclear weapons are used. All simulators of a nuclear war conclude in the inevitable figure of millions of deaths and an incalculable number of people affected by radiation (
Nuclear Princeton 2019
). We already know about the immediate- and long-term aftermath of the Chernobyl disaster and the Hiroshima and Nagasaki nuclear bombings in World War II (Nuclear Princeton, Princeton Science and Global Security Nuclear War Simulation https://nuclearprinceton.princeton.edu/news/princeton-science-and-global-security-nuclear-war-simulation, 2019 (accessed 22 March 2022).
Douple et al., 2011
).- Douple EB
- Mabuchi K
- Cullings HM
- Preston DL
- Kodama K
- Shimizu Y
- Fujiwara S
- Shore RE.
Long-term radiation-related health effects in a unique human population: lessons learned from the atomic bomb survivors of Hiroshima and Nagasaki.
Disaster Med Public Health Prep. 2011; 5 (Suppldoi: 10.1001%2Fdmp.2011.21): S122-S133
Another threat is the use of biologic and chemical weapons that disseminate biologic agents or toxins to cause harm, disease, and death of humans or animals and harm the environment (
Jansen et al., 2014
; Ekzayez et al., 2020
). In no way can this type of warfare be local or easy to contain. The global scientific community must warn the world leaders about the abyss into which humanity can fall if consensus is not reached in a timely manner to avoid self-destruction.After the use of nuclear weapons, there will be no winners among survivors. The health systems, especially in the countries most affected by radiation, will have to deal with its short-, medium-, and long-term effects on the population. It is time that states directly or indirectly affected by the Ukraine and Russia conflict cooperate bilaterally or multilaterally to stop the ongoing war.
Declarations
Founding source
Universidad Tecnológica Centroamericana, Honduras.
Ethical approval
Not applicable
Authors’ contribution
CR and RMD developed the concept, reviewed the literature, and wrote the manuscript.
Declaration of Competing Interest
All authors declare no competing interest related to this paper.
References
- Armed conflict and human displacement may lead to an increase in the burden of tuberculosis in Europe.Int J Infect Dis. 2022; S1201–-9712: 00180-00181https://doi.org/10.1016/j.ijid.2022.03.040
- Long-term radiation-related health effects in a unique human population: lessons learned from the atomic bomb survivors of Hiroshima and Nagasaki.Disaster Med Public Health Prep. 2011; 5 (Suppldoi: 10.1001%2Fdmp.2011.21): S122-S133
- Chemical weapons and public health: assessing impact and responses.J Public Health (Oxf). 2020; 42: e334-e342https://doi.org/10.1093/pubmed/fdz145
- Biological warfare, bioterrorism, and biocrime.Clin Microbiol Infect. 2014; 20: 488-496https://doi.org/10.1111/1469-0691.12699
- Strengthening the COVID-19 pandemic response, global leadership, and international cooperation through global health diplomacy.Health Promot Perspect. 2020; 10 (doi: 10.34172%2Fhpp.2020.48): 300-305
- Multi-country collaboration in responding to global infectious disease threats: lessons for Europe from the COVID-19 pandemic.Lancet Reg Health Eur. 2021; 9100221https://doi.org/10.1016/j.lanepe.2021.100221
Nuclear Princeton, Princeton Science and Global Security Nuclear War Simulation https://nuclearprinceton.princeton.edu/news/princeton-science-and-global-security-nuclear-war-simulation, 2019 (accessed 22 March 2022).
- Emergence of new SARS-CoV-2 Variant of Concern Omicron (B.1.1.529) - highlights Africa's research capabilities, but exposes major knowledge gaps, inequities of vaccine distribution, inadequacies in global COVID-19 response and control efforts.Int J Infect Dis. 2022; 114: 268-272https://doi.org/10.1016/j.ijid.2021.11.040
- A long-term perspective on immunity to COVID.Nature. 2021; 595: 359-360https://doi.org/10.1038/d41586-021-01557-z
- Herd immunity: understanding COVID-19.Immunity. 2020; 52: 737-741https://doi.org/10.1016/j.immuni.2020.04.012
Article info
Publication history
Published online: April 11, 2022
Accepted:
April 7,
2022
Received:
April 5,
2022
Identification
Copyright
© 2022 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
User license
Creative Commons Attribution – NonCommercial – NoDerivs (CC BY-NC-ND 4.0) | How you can reuse 
Elsevier's open access license policy
Creative Commons Attribution – NonCommercial – NoDerivs (CC BY-NC-ND 4.0)
Permitted
For non-commercial purposes:
- Read, print & download
- Redistribute or republish the final article
- Text & data mine
- Translate the article (private use only, not for distribution)
- Reuse portions or extracts from the article in other works
Not Permitted
- Sell or re-use for commercial purposes
- Distribute translations or adaptations of the article
Elsevier's open access license policy
